Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Cell & Gene Therapy

Stem cell research and commercialization in China...

TriArm Therapeutics Completes $20 Million Series A Round for Cell Therapies

CASI Acquires Global Rights To CD19 T-Cell Therapy; Will Make $11.6 Million Investment

Wall Street Journal: Dr. Jiankui He, the Man Who Edited China Embryos, Was a Product of the System

Cytovant of China Enters $1 Billion Deal for Four Medigene Immunotherapies

China Approves Merck's Keytruda, a PD-1 Drug, for First Line NSCLC

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events

 

China Showcase 2020

San Francisco, USA

January 12, 2020

ChinaBio Partnering Forum 2020

Suzhou, China

May 6-7, 2020

Other Events

CHINA HEALTHCARE SUMMIT 2019

Shanghai, China

November 18-20, 2019